News
News releases on January 7, 2024
Every news release public companies put out on January 7, 2024 (UTC): 15 news releases, newest first. Open any release to read it.
Press Release Jan 07 2024
Nandani Creation Ltd. · Jan 7, 2024
Stepping down of Mr. Sujendra Ranjanan Mather from the post of Alternate Director.
Vidullanka PLC · Jan 7, 2024
Disclosure in terms of rule 9.6.3 of the listing rules
Hayleys Fabric PLC · Jan 7, 2024
Corporate disclosure
Talawakelle Tea Estates PLC · Jan 7, 2024
Ultragenyx Reports Preliminary 2023 Revenue; Guidance for 2024 Revenue and Cash Usage; Pipeline Updates and 2024 Milestones
Ultragenyx Pharmaceutical Inc. · Jan 7, 2024
RxSight, Inc. Announces Preliminary Unaudited Fourth Quarter and Full-Year 2023 Financial and Operational Results and 2024 Guidance
RxSight, Inc. · Jan 7, 2024
IDEAYA Biosciences Announces Participation at the 42nd Annual J.P. Morgan Healthcare Conference and 2024 Corporate Guidance
IDEAYA Biosciences, Inc. · Jan 7, 2024
Heron Therapeutics Announces Partnership with CrossLink Life Sciences to Expand Promotional Effort for ZYNRELEF®, the First and Only Non-...
Heron Therapeutics, Inc. · Jan 7, 2024
Gentex Announces eSight Acquisition Set to Showcase Advanced Vision Tech at CES 2024
Gentex Corporation · Jan 7, 2024
Exelixis Announces Preliminary Fiscal Year 2023 Financial Results, Provides 2024 Financial Guidance, and Outlines Key Priorities and Mile...
Exelixis, Inc. · Jan 7, 2024
Exagen Inc. Announces Select Preliminary Full-Year 2023 Results and Reaffirms Guidance
Exagen Inc. · Jan 7, 2024
Castle Biosciences Announces Preliminary Fourth Quarter and Full-Year 2023 Results
Castle Biosciences, Inc. · Jan 7, 2024
Caribou Biosciences Appoints Tim Kelly as Chief Technology Officer and Highlights Multiple Clinical Catalysts Expected in 2024
Caribou Biosciences, Inc. · Jan 7, 2024
Annexon Outlines 2024 Priorities with Late-Stage Clinical Milestones Across Upstream Complement Portfolio for Autoimmune, Ophthalmic and ...
Annexon, Inc. · Jan 7, 2024
Alnylam Announces Preliminary* Fourth Quarter and Full Year 2023 Global Net Product Revenues and Provides Additional Updates
Alnylam Pharmaceuticals, Inc. · Jan 7, 2024